太陽能(000591.SZ):鎮江公司智能製造一期項目中1.5GW高效太陽能電池組件智能製造項目開工
格隆匯1月12日丨太陽能(000591.SZ)公佈,2022年1月12日,鎮江公司智能製造一期項目中1.5GW高效太陽能電池組件智能製造項目在鎮江新區新能源產業園開工。該項目主要產品為大尺寸高效太陽能電池組件,投產後可實現1.5GW以上的高效光伏組件年生產能力,將進一步推動鎮江公司規模化、品牌化發展。
目前1.5GW高效太陽能電池組件智能製造項目處於工程建設階段,距離投產運營尚需一定時間。公司將積極推進項目的建設進程,並根據項目進展情況,及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.